Form 4 for PGEN PRECIGEN, INC.
Accepted 2026-08-25 17:27:09 ET · period of report 2026-08-21 · accession 0000950103-26-012872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-25 17:27 | 2026-08-21+ | PGEN | Shah Rutul R | COO | M - OptEx | $2.33 | +57.5K | 484.2K | +13% | +$134.0K |
| DMT | 2026-08-25 17:27 | 2026-08-21+ | PGEN | Shah Rutul R | COO | S - Sale+OE | $7.50 | -50.0K | 468.9K | -10% | -$375.0K |
| DT | 2026-08-25 17:27 | 2026-08-23 | PGEN | Shah Rutul R | COO | F - Tax | $7.20 | -3,647 | 468.9K | -0.8% | -$26.3K |
| DMT | 2026-08-25 17:27 | 2026-08-21+ | PGEN | Shah Rutul R | COO | M - OptEx | $0.00 | -57.5K | 73.3K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-21 | M | A | 34,658 | $2.33 | 499,670 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-21 | S | D | 34,658 | $7.50 | 465,012 | D | — | — | (F1) Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. |
| 3 | Common | Common Stock | 2026-08-23 | M | A | 7,500 | — | 472,512 | D | — | — | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| 4 | Common | Common Stock | 2026-08-23 | F | D | 3,647 | $7.20 | 468,865 | D | — | — | (F3) Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs. |
| 5 | Common | Common Stock | 2026-08-25 | M | A | 15,342 | $2.33 | 484,207 | D | — | — | |
| 6 | Common | Common Stock | 2026-08-25 | S | D | 15,342 | $7.50 | 468,865 | D | — | — | (F1) Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. |
| 7 | Derivative | Option to Purchase Common Stock (Right to Buy) | 2026-08-21 | M | D | 34,658 | $0.00 | 88,646 | D | $2.33 · — to 2032-02-02 | 34,658 Common Stock | (F4) The stock options are fully vested. |
| 8 | Derivative | Restricted Stock Units | 2026-08-23 | M | D | 7,500 | $0.00 | 57,292 | D | — · — to — | 7,500 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F5) Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026. (F5) Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026. |
| 9 | Derivative | Option to Purchase Common Stock (Right to Buy) | 2026-08-25 | M | D | 15,342 | $0.00 | 73,304 | D | $2.33 · — to 2032-02-02 | 15,342 Common Stock | (F4) The stock options are fully vested. |